We are pleased to welcome AUSiMED Fellow Inbar Irron, a PhD candidate from Rambam Medical Center to Australia. During her fellowship, Inbar will obtain training in ovarian cancer translational research at the Hudson Institute. At the completion of her fellowship she will use her newly acquired knowledge to advance the Ovarian Cancer research collaboration between Dr Ruth Perets, Rambam Hospital and Assoc Prof Ron Firestein, Hudson Institute.
We are pleased to introduce Deborah Travers, appointed as a Non-Executive Director, and member of the AUSiMED Development Committee in early 2023. Deborah has an academic background in Genetics and Biochemistry. Her career spans merchant banking, business, and real estate. Deborah‘s multi-faceted interests and vast experience come together seamlessly at AUSiMED where she can interweave her commercial experience with her passion for science, health, nutrition, and technology.
“I am looking forward to advancing AUSiMED’s ground-breaking work and strengthening the bond between Australia and Israel for the betterment of people worldwide.”
In 2022, with COVID still high on the public health agenda, AUSiMED facilitated the visit to Israel, of fifteen of Australia’s leading Public Health experts.
Led by Professor Sharon Lewin, the Director of the Doherty Institute, the 15-person group, including the Chief Health Officers (CHO) of NSW and South Australia, the Deputy CHO of Victoria, engaged with their Israeli counterparts in a rewarding exchange of learnings from the battle with COVID-19. This was made possible by the generosity of our supporters.
A further major outcome of the Lewin mission was the connections made between the Australian delegates and their Israel counterparts in the Digital Health Innovation space.
The benefits of shared experiences are highlighted by delegation members ProfJodie McVernon, Director of Doherty Epidemiology, Doherty Institute and Dr Fergus Gardiner, Royal Flying Doctor Service (RFDS), Director of National Emergency Response, Public Health and Research.
“We can learn from Israel about turning complex record systems into data sets that can used as ‘information for action’ by practitioners and epidemiologists.”ProfJodie McVernon
“The introduction ofgame-changing Israeli telehealth technology to facilitate remote medical examinations could result in major health benefits for Australians living with chronic diseases and people living in remote and rural communities.” Dr Fergus Gardiner
AUSTRALIA-ISRAEL MEDICAL RESEARCH (AUSiMED) is celebrating TEN years of achievement.
AUSiMED was launched in the strong belief that Australia and Israel, two world leaders in clinical research, could, through collaborative endeavour, deliver outcomes beneficial to both countries AND the global community.
We are proud of the progress we are making, delivering on this Mission.
2022 was a particularly impactful example of the power of our cross-border model. In September 2022, AUSiMED hosted the 2nd Jerusalem International Conference on Trauma and Mental Health which delivered a powerful program covering innovative approaches to the treatment of PTSD to participants from Europe, the middle east, Australia, and North America.
In 2022 AUSiMED also facilitated the visit to Israel, of fifteen of Australia’s leading Public Health experts. Led by Professor Sharon Lewin, the Director of the Doherty Institute, the 15-person group, including the Chief Health Officers (CHO) of NSW and South Australia, the Deputy CHO of Victoria, engaged with their Israeli counterparts in a rewarding exchange of learnings from the battle with COVID-19.
What is particularly gratifying is that we were able to deliver on these major initiatives while continuing and deepening our commitment to world-leading Australia-Israel collaborative clinical research initiatives and Fellowships.
The list of AUSiMED’s achievements is long and it is continuing to grow and deepen due to the ongoing, generous support we are receiving from our donor community.
2023-24 Paediatric Kidney Disease (seeking funding for Years 2 and 3) |
2023-23 Ovarian Cancer |
2022 2nd International Conference on Trauma and Mental Health |
2020-22 Orygen-Enosh Youth Mental Health Learning Exchange |
2016-20 Goshen Project |
2016-18 Dream Doctors |
2016-17 Bowel Cancer |
2016-17 Triple negative breast cancer |
2014-ongoing Lowy Paediatric Fellowships |
2014-ongoing Israel Short Stays Program |
2014 Australia-Israel Paediatric Research Symposium, Melbourne. |
Australia and Israel are strategic partners in trade, culture and health. In the wake of COVID-19, AUSiMED recognised an opportunity to distil and exchange the lessons learnt by Australia and Israel in their response to the pandemic. In September 2022, a high-level Delegation of Australian public health officials and expert scientists participated in a COVID[1]19 Learning Exchange Mission to Israel. The mission was organised by AUSiMED with the active support of the Israel Embassy in Canberra.
The delegation was led by Professor Sharon Lewin AO, Director of the Peter Doherty Institute for Infection and Immunity and Co-Chair of the National COVID-19 Health and Research Advisory Council (NCHRAC).
During the 5-day visit the delegation met with many of Israel’s top public health officials and practitioners to develop person-to-person networks between Australia and Israel and inform ongoing management of the COVID-19 pandemic and potentially other infectious diseases going forward.
The Lewin COVID-19 Delegation was hugely successful on a range of important dimensions while also meeting AUSiMED’s mission of enhancing global health outcomes through engagement between Australia and Israel. A number of opportunities for future collaboration were identified during and following the mission, including:
A very exciting opportunity for the Royal Flying Doctors Service to trial an Israeli device enabling one of the major barriers to use of telehealth (being the inability to physically examine the patient) to be largely overcome;
Further engagement between Australian and Israeli data modelling experts regarding systems and approaches to data linkage, machine learning, and predictive algorithms; and
Opportunities for new AUSiMED fellowships in several areas.